feasibility

Metastatic Breast Cancer: Prevalence, Past Experience, and Competition

According to IARC Globocan, 2008, there are about 1.38 million new cases and 458 000 breast cancer deaths each year. This is the most common cancer among women worldwide in both developed as well as developing countries.  The number of deaths mainly depends on the early detection of the disease. …

Metastatic Breast Cancer: Prevalence, Past Experience, and Competition Read More »

The Past, Present and Future of Public Clinical Trial Registries

In my article on the 3 main limitations to public clinical trial registries, I mentioned that public registries were not designed for the purposes of feasibility. While this is true, the scientific community was intended as one of the beneficiaries of the initiative right from the start.  To understand better …

The Past, Present and Future of Public Clinical Trial Registries Read More »

The 3 Main Limitations To Public Clinical Trial Registers (And Why They’re Still The Go-To for Feasibility)

Public clinical trial registers were designed to comply with regulations (and make the public aware of past, ongoing, and future clinical trials), not for the purposes of clinical trial feasibility. This becomes abundantly clear once you try to gather the data you need for site selection or calculate recruitment rate …

The 3 Main Limitations To Public Clinical Trial Registers (And Why They’re Still The Go-To for Feasibility) Read More »

Data sources in Feasibility for clinical trials? | Part 1

Feasibility for clinical trials is all about finding the right sources of data, being able to analyse them and then make decisions for country selection, sites and investigators, as well as patient recruitment strategies. It sounds simple and yet, when it comes to execution it’s very complicated. Therefore feasibility specialists …

Data sources in Feasibility for clinical trials? | Part 1 Read More »

Global Clinical Operations Director’s insights from 2008 and top lessons that apply during COVID-19

Estrella Garcia is with Almirall for 27 years and is currently their Global Clinical Operations Director. She was with the pharma company during the last financial crisis and went through some really hard times for the company. She shares with Maya Zlatanova, CEO of FindMeCure Ltd., the lessons she learned …

Global Clinical Operations Director’s insights from 2008 and top lessons that apply during COVID-19 Read More »

Digital transformation driven by COVID-19 pandemic

People adapt to social isolation during Covid-19 and find ways to stay connected to one another and get their work done. The clinical research industry can also adapt and keep moving forward by leveraging technology to keep operations going. Watch the video to find out how Covid-19 is driving this …

Digital transformation driven by COVID-19 pandemic Read More »

Scroll to Top